5fr3: Difference between revisions
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==X-ray crystal structure of aggregation-resistant protective antigen of Bacillus anthracis (mutant S559L T576E)== | ==X-ray crystal structure of aggregation-resistant protective antigen of Bacillus anthracis (mutant S559L T576E)== | ||
<StructureSection load='5fr3' size='340' side='right' caption='[[5fr3]], [[Resolution|resolution]] 1.94Å' scene=''> | <StructureSection load='5fr3' size='340' side='right'caption='[[5fr3]], [[Resolution|resolution]] 1.94Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[5fr3]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FR3 OCA]. For a <b>guided tour on the structure components</b> use [ | <table><tr><td colspan='2'>[[5fr3]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Bacillus_anthracis Bacillus anthracis]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FR3 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5FR3 FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr> | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.935Å</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5fr3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fr3 OCA], [https://pdbe.org/5fr3 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5fr3 RCSB], [https://www.ebi.ac.uk/pdbsum/5fr3 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5fr3 ProSAT]</span></td></tr> | |||
</table> | </table> | ||
== Function == | == Function == | ||
[ | [https://www.uniprot.org/uniprot/PAG_BACAN PAG_BACAN] One of the three proteins composing the anthrax toxin, the agent which infects many mammalian species and that may cause death. PA binds to a receptor (ATR) in sensitive eukaryotic cells, thereby facilitating the translocation of the enzymatic toxin components, edema factor and lethal factor, across the target cell membrane. PA associated with LF causes death when injected, PA associated with EF produces edema. PA induces immunity to infection with anthrax. | ||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
Natural selection shapes protein solubility to physiological requirements and recombinant applications that require higher protein concentrations are often problematic. This raises the question whether the solubility of natural protein sequences can be improved. We here show an anti-correlation between the number of aggregation prone regions (APRs) in a protein sequence and its solubility, suggesting that mutational suppression of APRs provides a simple strategy to increase protein solubility. We show that mutations at specific positions within a protein structure can act as APR suppressors without affecting protein stability. These hot spots for protein solubility are both structure and sequence dependent but can be computationally predicted. We demonstrate this by reducing the aggregation of human alpha-galactosidase and protective antigen of Bacillus anthracis through mutation. Our results indicate that many proteins possess hot spots allowing to adapt protein solubility independently of structure and function. | |||
Structural hot spots for the solubility of globular proteins.,Ganesan A, Siekierska A, Beerten J, Brams M, Van Durme J, De Baets G, Van der Kant R, Gallardo R, Ramakers M, Langenberg T, Wilkinson H, De Smet F, Ulens C, Rousseau F, Schymkowitz J Nat Commun. 2016 Feb 24;7:10816. doi: 10.1038/ncomms10816. PMID:26905391<ref>PMID:26905391</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
</div> | |||
<div class="pdbe-citations 5fr3" style="background-color:#fffaf0;"></div> | |||
== References == | |||
<references/> | |||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Bacillus anthracis]] | ||
[[Category: Beerten | [[Category: Large Structures]] | ||
[[Category: Brams | [[Category: Beerten J]] | ||
[[Category: | [[Category: Brams M]] | ||
[[Category: | [[Category: De Baets G]] | ||
[[Category: | [[Category: De Smet F]] | ||
[[Category: | [[Category: Gallardo R]] | ||
[[Category: Langenberg | [[Category: Ganesan A]] | ||
[[Category: Ramakers | [[Category: Langenberg T]] | ||
[[Category: Rousseau | [[Category: Ramakers M]] | ||
[[Category: Schymkowitz | [[Category: Rousseau F]] | ||
[[Category: Siekierska | [[Category: Schymkowitz J]] | ||
[[Category: Siekierska A]] | |||
[[Category: Ulens | [[Category: Ulens C]] | ||
[[Category: Wilkinson | [[Category: Wilkinson H]] | ||
[[Category: | [[Category: Van Durme J]] | ||
[[Category: | [[Category: Van der Kant R]] | ||